By: Christopher A. Parrella, Esq., CPC, CHC, CPCO

The landscape of healthcare technology is rapidly evolving, and artificial intelligence (AI) is at the forefront of this transformation. The U.S. Department of Health and Human Services (HHS) has taken a monumental step by finalizing a rule specifically targeting AI in healthcare, focusing on algorithm transparency and information sharing. As experts in healthcare law at Parrella Health Law, we recognize the profound implications of this development for healthcare providers and the broader medical community.

The new rule, titled Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (HTI-1), is a comprehensive 916-page document. Micky Tripathi, the National Coordinator for Health Information Technology at HHS, described this rule as a significant stride in establishing responsible AI use within the industry.

Tripathi emphasized that the HTI-1 Rule aims to enhance transparency and risk management of AI-based technologies in healthcare delivery. The rule is grounded in principles of fairness, appropriateness, validity, effectiveness, and safety. These guidelines resonate with our work at Parrella Health Law, where we continuously stress the importance of legal and ethical compliance in the rapidly evolving digital healthcare landscape.

In alignment with President Joe Biden’s executive order, the rule aims to harness AI for developing life-saving drugs, addressing equity in medical fields, and solving healthcare industry problems. The rule updates certification criteria for decision support interventions, patient demographics and observations, electronic case reporting, and the use of electronic health information.

Tripathi highlighted the critical role of electronic health record systems, which are used by a vast majority of hospitals and physicians’ offices in the U.S. These systems are increasingly feeding data into machine learning algorithms and influencing day-to-day decision-making processes that directly impact patient lives.

The issue of data security remains a priority. The AI’s potential to protect patient data has been a subject of concern for both the Biden administration and Congress. Representative Frank Pallone, D-N.J., raised questions about safeguards for patients’ information when used in training healthcare-related AI systems. Tripathi acknowledged the unique challenges posed by AI, especially considering that much health-related information exists outside the realm of HIPAA (Health Insurance Portability and Accountability Act).

Conversely, there are concerns about over-regulation. House E&C Chair Cathy McMorris Rodgers, R-Wash., cautioned against stifling technological innovation through excessive regulation, emphasizing the need for a balanced approach that leverages AI while upholding values of human rights, individual liberty, the free market, and limited government.

The commitment to a responsible use of AI is also shared by private entities. Twenty-eight companies and healthcare providers have pledged to ensure a safe, secure, and trustworthy use of AI, as announced by the Biden administration.

HHS’s role in AI extends further, as highlighted by Kevin Eike, a spokesperson for the department. The U.S. Food and Drug Administration has approved over 690 AI-enabled devices to improve medical diagnoses and treatment. The U.S. National Institutes of Health are also utilizing AI in treatment areas such as cancer, Alzheimer’s Disease, and mental illness.

As healthcare defense and compliance attorneys, we at Parrella Health Law understand the complexities and challenges that come with integrating AI into healthcare. The new HHS rule is a crucial step towards a future where AI not only enhances healthcare delivery but does so within a framework of transparency, safety, and ethical responsibility. Our role is to navigate these new regulations, ensuring our clients are not only compliant but also at the forefront of this exciting and transformative era in healthcare.

Christopher Parrella, ESQ, CPC, CHC, CPCO, is the founding partner of Parrella Health Law in Boston, Mass. The firm focuses exclusively on healthcare defense and compliance matters. Chris also travels the country on behalf of a wide range of healthcare organizations, lecturing on a variety of health care enforcement and compliance topics. Chris is one of a handful of health care attorney’s that are also Certified Professional Coders (CPC) and is a member of the AAPC’s National Legal Advisory Board and Ethics Committee.  He is also a Certified Professional Compliance Officer (CPCO) and Certified in Health Care Compliance (CHC.)Christopher Parrella, ESQ, CPC, CHC, CPCO, is the founding partner of Parrella Health Law in Boston, Mass. The firm focuses exclusively on healthcare defense and compliance matters. Chris also travels the country on behalf of a wide range of healthcare organizations, lecturing on a variety of health care enforcement and compliance topics. Chris is one of a handful of health care attorney’s that are also Certified Professional Coders (CPC) and is a member of the AAPC’s National Legal Advisory Board and Ethics Committee.  He is also a Certified Professional Compliance Officer (CPCO) and Certified in Health Care Compliance (CHC.)